ClinConnect ClinConnect Logo
Search / Trial NCT06112431

Eye Health Intervention Study in Upper Manhattan

Launched by COLUMBIA UNIVERSITY · Oct 31, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Randomized Clinical Trial Implementation Outcomes Eye Health Intervention Glaucoma/Glaucoma Suspect Eye Health Screenings And Optometric Exams Leading Causes Of Eye Disease Telehealth Image Reading Vision Health Policy Roadmap

ClinConnect Summary

The Eye Health Intervention Study in Upper Manhattan (EYES-UM) aims to improve eye care for adults aged 40 and older who may not have easy access to eye health services. This study will provide eye screenings to people living in Upper Manhattan, focusing on those who are at risk for conditions like glaucoma, diabetic retinopathy, cataracts, and other vision problems. By partnering with local primary care offices and senior centers, the study plans to reach around 17,000 individuals who may not have had regular eye check-ups. If participants do not pass the eye screening, they will receive immediate care from an eye doctor and will get free eyeglasses if needed.

To be eligible for this study, participants must be at least 40 years old and able to live independently. Unfortunately, those with a serious illness that limits their life expectancy or who cannot understand the study's requirements due to conditions like dementia will not be able to participate. Throughout the study, which will last for two years, participants will receive support in scheduling follow-up eye exams and transportation if needed. This trial will not only help improve eye health in the community but will also evaluate the costs and benefits of the care provided compared to standard services.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals age 40 years or older.
  • Living independently.
  • Exclusion Criteria:
  • Self-reported terminal illness with life expectancy of less than 1 year.
  • Inability to provide informed consent due to dementia or other reason.

About Columbia University

Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Lisa A. Hark, PhD, MBA

Principal Investigator

Columbia University Department of Ophthalmology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported